News

Which Breast Cancer Model Should You Use? From ...

BREAST CANCER · ADC · ORGANOID · PDX Which Breast Cancer Model Should You Use? From Organoid Screening to PDX Validation For HER2 or TROP2 ADCs, targeted therapies and immuno-oncology...

Is p-Tau 217 Enough? Understanding the Alzheime...

ALZHEIMER'S RESEARCH · BLOOD BIOMARKERS · ULTRASENSITIVE IMMUNOASSAYS Is p-Tau 217 Enough? Understanding the Alzheimer's Blood Biomarker Panel Alzheimer's disease involves multiple biological processes that evolve over time. Combining biomarkers...

Your CUT&RUN Library Has Peaks. But How Do ...

EPIGENETICS · CUT&RUN · CUT&Tag Your CUT&RUN Library Has Peaks. But How Do You Know They Are Real? Successful library generation is only part of a chromatin profiling experiment. Reliable...

Same Cytokine Concentration. But Is the Biologi...

CYTOKINE · REPORTER CELLS · BIOACTIVITY ASSAYS Same Cytokine Concentration. But Is the Biological Activity the Same? Measuring cytokine concentration and measuring cytokine function answer two different questions. Reporter cell-based...

Your Compound Inhibits the Kinase In Vitro. But...

DRUG DISCOVERY · KINASE SCREENING · NanoBRET Your Compound Inhibits the Kinase In Vitro. But Does It Actually Work Inside the Cell? A single IC50 value rarely tells the complete...

A Practical IVT mRNA QC Workflow: From Transcri...

Dana Bioscience RNA QC Guide A Practical IVT mRNA QC Workflow From transcription and purification to RNA size, dsRNA impurity and residual T7 RNA polymerase. Producing an IVT RNA transcript...